Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ribociclib and aromatase inhibitor in elderly patients with HR+ metastatic breast cancer
NCT03477396Phase 2Completed
- Sponsor
- City of Hope
- Start
- Jun 2018
- Primary completion
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ribociclib in breast cancer, sponsored by City of Hope. Started Jun 2018; status: completed.
02
Drugs
ribociclib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT03477396.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03477396.